ABOUT CELLVANTA
Built to bridge science, execution and capital.
Cellvanta is a boutique advisory capability for biotech with particular depth in advanced therapies. We combine scientific expertise with development, investment to help programmes move forward, faster.
OUR MISSION
Our mission is simple: bridge the gap between science, execution and capital supporting the programmes that bring frontier biotech closer to real-world impact.
WHAT MAKES US DIFFERENT
Built for the difficult questions
Our edge sits at the overlapping points of scientific depth and independent advice
Technical depth
Years of hands-on experience across advanced therapy programmes in flow cytometry, potency, comparability, CMC and analytics. We engage actively with how AI is reshaping the modern lab, from electronic notebooks and data integration to trend analytics and decision forecasting.
Independent advice
Unbiased, practical and decision-focused. We work alongside founders, teams and investors. Not as a vendor, but as a partner.
HOW WE WORK
Values that shape every engagement.
We work in a way that's grounded, structured and aligned with the outcomes that matter most.
Execution-grounded expertise
Strategic flexibility
Ecosystems at the core
Investment-aware thinking
LED BY
Siddharth Krishnan, Founder
Working at the intersection of biotech development, CMC execution and investment decision-making.
Sid supports biotech teams and investors navigating analytical risk, comparability and programme readiness by translating technology readiness, analytical robustness and CMC risk into decision-ready intelligence at the senior stakeholder level. His work focuses on the translation gap: where rigorous science isn't yet legible to capital, or where analytical strategy hasn't kept pace with the science.
Driven by purpose. Focused on impact.
We exist to help biotech programmes move forward, faster through better decisions, stronger execution, curated networks and partnerships that work.